The food-borne infections listeriosis and shigatoxigenic Escherichia coli are increasing in the EU/EEA and were in 2022 at levels higher than before the COVID-19 pandemic.
A genomic cluster of Listeria monocytogenes infections has been identified in the EU/EEA and the United Kingdom, according to a Rapid Outbreak Assessment released today by ECDC and EFSA.
Campylobacteriosis and salmonellosis were the most frequently reported zoonotic diseases in humans in the EU in 2022. For West Nile virus, an increase of the number of infections was observed.
Between 2018 and 2020, nearly 20 000 surgical site infections (SSIs) were reported from a total of over 1.2 million surgical procedures in 13 EU/EEA countries participating in ECDC-coordinated SSI surveillance. Over 2 500 hospitals are part of this surveillance network.
Hepatitis A cases in 2021 were at their lowest levels since EU-level hepatitis A surveillance began in 2007, while five other food and waterborne diseases are rising towards pre-pandemic levels. The information is revealed in the Annual Epidemiological Report 2021, of which six chapters are published today by ECDC.
A collaborative study between ECDC, the European Food Safety Authority (EFSA) and the European Union Reference Laboratory (EURL) for Listeria monocytogenes* found a relatively high degree of dissemination of certain listeriosis bacteria in the food chain and in the human population across the European Union (EU).
Nearly one in three foodborne outbreaks in the EU in 2018 were caused by Salmonella. This is one of the main findings of the annual report on trends and sources of zoonoses published today by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).
ECDC has identified a microbiological link between an outbreak of nine Listeria monocytogenes ST1247 cases in Denmark and nine additional cases reported between 2014 and 2018 in Estonia (2 cases) Finland (2), France (1) and Sweden (4).
On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.